OWD
BMY icon

Osborn Williams & Donohoe’s Bristol-Myers Squibb BMY Stock Holding History

Osborn Williams & Donohoe’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$5.68M Sell
101,890
-1,700
-2% -$104K 0.75% 42
2019
Q4 		$6.65M Buy
103,590
+37,904
+58% +$2.17M 0.66% 47
2019
Q3 		$3.33M Buy
65,686
+1,625
+3% +$76.4K 0.34% 81
2019
Q2 		$2.9M Sell
64,061
-2,195
-3% -$102K 0.3% 90
2019
Q1 		$3.05M Buy
66,256
+13,514
+26% +$673K 0.31% 88
2018
Q4 		$2.74M Sell
52,742
-165
-0.3% -$8.87K 0.48% 61
2018
Q3 		$3.28M Buy
52,907
+375
+0.7% +$22.3K 0.51% 54
2018
Q2 		$2.91M Sell
52,532
-130
-0.2% -$7.02K 0.49% 59
2018
Q1 		$3.33M Hold
52,662
– – 0.58% 50
2017
Q4 		$3.23M Buy
52,662
+125
+0.2% +$7.82K 0.55% 53
2017
Q3 		$3.35M Sell
52,537
-5,760
-10% -$336K 0.6% 51
2017
Q2 		$3.25M Sell
58,297
-1,340
-2% -$72.9K 0.59% 52
2017
Q1 		$3.24M Sell
59,637
-505
-0.8% -$27.7K 0.59% 53
2016
Q4 		$3.52M Sell
60,142
-487
-0.8% -$26.6K 0.66% 48
2016
Q3 		$3.27M Sell
60,629
-390
-0.6% -$25.1K 0.63% 49
2016
Q2 		$4.49M Sell
61,019
-81
-0.1% -$5.72K 0.87% 35
2016
Q1 		$3.9M Buy
61,100
+1,086
+2% +$68.5K 0.78% 41
2015
Q4 		$4.13M Sell
60,014
-680
-1% -$44.9K 0.85% 41
2015
Q3 		$3.66M Sell
60,694
-885
-1% -$56.1K 0.79% 44
2015
Q2 		$4.06M Sell
61,579
-2,926
-5% -$193K 0.82% 45
2015
Q1 		$4.16M Sell
64,505
-3,784
-6% -$237K 0.81% 43
2014
Q4 		$4.03M Buy
68,289
+2,655
+4% +$150K 0.79% 42
2014
Q3 		$3.36M Buy
65,634
+3,085
+5% +$154K 0.7% 46
2014
Q2 		$3.04M Buy
62,549
+475
+0.8% +$23.4K 0.63% 51
2014
Q1 		$3.23M Sell
62,074
-505
-0.8% -$26.9K 0.71% 46
2013
Q4 		$3.33M Buy
62,579
+1,600
+3% +$81.5K 0.75% 45
2013
Q3 		$2.82M Sell
60,979
-2,150
-3% -$94.4K 0.69% 49
2013
Q2 		$2.82M Buy
+63,129
New +$2.74M 0.74% 44

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Osborn Williams & Donohoe's BMY Position: Q1 2020 in Review

Osborn Williams & Donohoe reduced its Bristol-Myers Squibb (BMY) stake by 1.6% in Q1 2020, selling an estimated $104K and leaving 101,890 shares worth $5.68M. The position accounts for 0.75% of the portfolio, ranked #42.

Osborn Williams & Donohoe first reported a position in BMY in Q2 2013 and has held it in 28 quarters since. The position peaked at $6.65M in Q4 2019. 2,148 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

  • Osborn Williams & Donohoe held 101,890 shares of Bristol-Myers Squibb worth $5.68M as of Q1 2020.
  • Osborn Williams & Donohoe sold 1,700 Bristol-Myers Squibb shares in Q1 2020, an estimated $104K.
  • Bristol-Myers Squibb made up 0.75% of Osborn Williams & Donohoe's portfolio in Q1 2020, its #42 holding.
  • Osborn Williams & Donohoe first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 28 quarters since.
  • Osborn Williams & Donohoe's Bristol-Myers Squibb position peaked at $6.65M in Q4 2019.
  • 2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Osborn Williams & Donohoe's 13F filing for Q1 2020, filed 4 May 2020.